BIMI International Medical Inc.
BIMI International Medical Inc. BIMI Peers
See (BIMI) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BIMI | $0.00 | N/A | 9423.00 | N/A | -$6.39 | N/A |
| INSM | $68.12 | +1.34% | 12.41B | -11.49 | -$5.93 | N/A |
| WBA | $11.29 | +0.98% | 9.76B | -1.69 | -$6.69 | +6.64% |
| ONC | $228.38 | +1.16% | 1.74B | -62.91 | -$3.63 | N/A |
| LFMDP | $24.19 | -0.63% | 1.10B | -10.72 | -$2.26 | N/A |
| HROWL | $25.28 | +0.32% | 927.77M | N/A | N/A | N/A |
| HROWM | $26.24 | -1.74% | 906.02M | N/A | N/A | +11.32% |
| LFMD | $10.72 | +10.86% | 487.20M | -32.48 | -$0.33 | N/A |
| HITI | $2.36 | +2.16% | 191.02M | -39.33 | -$0.06 | N/A |
| PETS | $3.86 | +2.66% | 79.73M | 386.00 | $0.01 | N/A |
Stock Comparison
BIMI vs INSM Comparison
BIMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIMI stands at 9423.00. In comparison, INSM has a market cap of 12.41B. Regarding current trading prices, BIMI is priced at $0.00, while INSM trades at $68.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIMI currently has a P/E ratio of N/A, whereas INSM's P/E ratio is -11.49. In terms of profitability, BIMI's ROE is -2.93%, compared to INSM's ROE of -4.47%. Regarding short-term risk, BIMI is less volatile compared to INSM. This indicates potentially lower risk in terms of short-term price fluctuations for BIMI.
BIMI vs WBA Comparison
BIMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIMI stands at 9423.00. In comparison, WBA has a market cap of 9.76B. Regarding current trading prices, BIMI is priced at $0.00, while WBA trades at $11.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIMI currently has a P/E ratio of N/A, whereas WBA's P/E ratio is -1.69. In terms of profitability, BIMI's ROE is -2.93%, compared to WBA's ROE of -0.55%. Regarding short-term risk, BIMI is less volatile compared to WBA. This indicates potentially lower risk in terms of short-term price fluctuations for BIMI.
BIMI vs ONC Comparison
BIMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIMI stands at 9423.00. In comparison, ONC has a market cap of 1.74B. Regarding current trading prices, BIMI is priced at $0.00, while ONC trades at $228.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIMI currently has a P/E ratio of N/A, whereas ONC's P/E ratio is -62.91. In terms of profitability, BIMI's ROE is -2.93%, compared to ONC's ROE of -0.12%. Regarding short-term risk, BIMI is less volatile compared to ONC. This indicates potentially lower risk in terms of short-term price fluctuations for BIMI.
BIMI vs LFMDP Comparison
BIMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIMI stands at 9423.00. In comparison, LFMDP has a market cap of 1.10B. Regarding current trading prices, BIMI is priced at $0.00, while LFMDP trades at $24.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIMI currently has a P/E ratio of N/A, whereas LFMDP's P/E ratio is -10.72. In terms of profitability, BIMI's ROE is -2.93%, compared to LFMDP's ROE of +2.33%. Regarding short-term risk, BIMI is less volatile compared to LFMDP. This indicates potentially lower risk in terms of short-term price fluctuations for BIMI.
BIMI vs HROWL Comparison
BIMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIMI stands at 9423.00. In comparison, HROWL has a market cap of 927.77M. Regarding current trading prices, BIMI is priced at $0.00, while HROWL trades at $25.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIMI currently has a P/E ratio of N/A, whereas HROWL's P/E ratio is N/A. In terms of profitability, BIMI's ROE is -2.93%, compared to HROWL's ROE of -0.36%. Regarding short-term risk, BIMI and HROWL have similar daily volatility (0.00).
BIMI vs HROWM Comparison
BIMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIMI stands at 9423.00. In comparison, HROWM has a market cap of 906.02M. Regarding current trading prices, BIMI is priced at $0.00, while HROWM trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIMI currently has a P/E ratio of N/A, whereas HROWM's P/E ratio is N/A. In terms of profitability, BIMI's ROE is -2.93%, compared to HROWM's ROE of -0.28%. Regarding short-term risk, BIMI is less volatile compared to HROWM. This indicates potentially lower risk in terms of short-term price fluctuations for BIMI.
BIMI vs LFMD Comparison
BIMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIMI stands at 9423.00. In comparison, LFMD has a market cap of 487.20M. Regarding current trading prices, BIMI is priced at $0.00, while LFMD trades at $10.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIMI currently has a P/E ratio of N/A, whereas LFMD's P/E ratio is -32.48. In terms of profitability, BIMI's ROE is -2.93%, compared to LFMD's ROE of +2.33%. Regarding short-term risk, BIMI is less volatile compared to LFMD. This indicates potentially lower risk in terms of short-term price fluctuations for BIMI.
BIMI vs HITI Comparison
BIMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIMI stands at 9423.00. In comparison, HITI has a market cap of 191.02M. Regarding current trading prices, BIMI is priced at $0.00, while HITI trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIMI currently has a P/E ratio of N/A, whereas HITI's P/E ratio is -39.33. In terms of profitability, BIMI's ROE is -2.93%, compared to HITI's ROE of -0.05%. Regarding short-term risk, BIMI is less volatile compared to HITI. This indicates potentially lower risk in terms of short-term price fluctuations for BIMI.
BIMI vs PETS Comparison
BIMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIMI stands at 9423.00. In comparison, PETS has a market cap of 79.73M. Regarding current trading prices, BIMI is priced at $0.00, while PETS trades at $3.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIMI currently has a P/E ratio of N/A, whereas PETS's P/E ratio is 386.00. In terms of profitability, BIMI's ROE is -2.93%, compared to PETS's ROE of +0.00%. Regarding short-term risk, BIMI is less volatile compared to PETS. This indicates potentially lower risk in terms of short-term price fluctuations for BIMI.
BIMI vs YI Comparison
BIMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIMI stands at 9423.00. In comparison, YI has a market cap of 68.04M. Regarding current trading prices, BIMI is priced at $0.00, while YI trades at $7.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIMI currently has a P/E ratio of N/A, whereas YI's P/E ratio is -7.48. In terms of profitability, BIMI's ROE is -2.93%, compared to YI's ROE of +0.10%. Regarding short-term risk, BIMI is less volatile compared to YI. This indicates potentially lower risk in terms of short-term price fluctuations for BIMI.
BIMI vs RNTX Comparison
BIMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIMI stands at 9423.00. In comparison, RNTX has a market cap of 48.60M. Regarding current trading prices, BIMI is priced at $0.00, while RNTX trades at $2.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIMI currently has a P/E ratio of N/A, whereas RNTX's P/E ratio is -0.63. In terms of profitability, BIMI's ROE is -2.93%, compared to RNTX's ROE of -0.80%. Regarding short-term risk, BIMI is less volatile compared to RNTX. This indicates potentially lower risk in terms of short-term price fluctuations for BIMI.
BIMI vs RAD Comparison
BIMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIMI stands at 9423.00. In comparison, RAD has a market cap of 36.76M. Regarding current trading prices, BIMI is priced at $0.00, while RAD trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIMI currently has a P/E ratio of N/A, whereas RAD's P/E ratio is -0.05. In terms of profitability, BIMI's ROE is -2.93%, compared to RAD's ROE of +0.91%. Regarding short-term risk, BIMI is less volatile compared to RAD. This indicates potentially lower risk in terms of short-term price fluctuations for BIMI.
BIMI vs MEDS Comparison
BIMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIMI stands at 9423.00. In comparison, MEDS has a market cap of 13.28M. Regarding current trading prices, BIMI is priced at $0.00, while MEDS trades at $7.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIMI currently has a P/E ratio of N/A, whereas MEDS's P/E ratio is -0.31. In terms of profitability, BIMI's ROE is -2.93%, compared to MEDS's ROE of +0.22%. Regarding short-term risk, BIMI is less volatile compared to MEDS. This indicates potentially lower risk in terms of short-term price fluctuations for BIMI.
BIMI vs CJJD Comparison
BIMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIMI stands at 9423.00. In comparison, CJJD has a market cap of 9.95M. Regarding current trading prices, BIMI is priced at $0.00, while CJJD trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIMI currently has a P/E ratio of N/A, whereas CJJD's P/E ratio is -0.46. In terms of profitability, BIMI's ROE is -2.93%, compared to CJJD's ROE of -0.30%. Regarding short-term risk, BIMI is less volatile compared to CJJD. This indicates potentially lower risk in terms of short-term price fluctuations for BIMI.
BIMI vs NEUP Comparison
BIMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIMI stands at 9423.00. In comparison, NEUP has a market cap of 8.64M. Regarding current trading prices, BIMI is priced at $0.00, while NEUP trades at $4.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIMI currently has a P/E ratio of N/A, whereas NEUP's P/E ratio is 0.45. In terms of profitability, BIMI's ROE is -2.93%, compared to NEUP's ROE of -0.43%. Regarding short-term risk, BIMI is less volatile compared to NEUP. This indicates potentially lower risk in terms of short-term price fluctuations for BIMI.
BIMI vs SSY Comparison
BIMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIMI stands at 9423.00. In comparison, SSY has a market cap of 6.05M. Regarding current trading prices, BIMI is priced at $0.00, while SSY trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIMI currently has a P/E ratio of N/A, whereas SSY's P/E ratio is -2.05. In terms of profitability, BIMI's ROE is -2.93%, compared to SSY's ROE of +0.12%. Regarding short-term risk, BIMI is less volatile compared to SSY. This indicates potentially lower risk in terms of short-term price fluctuations for BIMI.
BIMI vs ATNFW Comparison
BIMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIMI stands at 9423.00. In comparison, ATNFW has a market cap of 4.74M. Regarding current trading prices, BIMI is priced at $0.00, while ATNFW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIMI currently has a P/E ratio of N/A, whereas ATNFW's P/E ratio is N/A. In terms of profitability, BIMI's ROE is -2.93%, compared to ATNFW's ROE of -1.47%. Regarding short-term risk, BIMI and ATNFW have similar daily volatility (0.00).
BIMI vs MDVL Comparison
BIMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIMI stands at 9423.00. In comparison, MDVL has a market cap of 2.91M. Regarding current trading prices, BIMI is priced at $0.00, while MDVL trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIMI currently has a P/E ratio of N/A, whereas MDVL's P/E ratio is -0.05. In terms of profitability, BIMI's ROE is -2.93%, compared to MDVL's ROE of -2.39%. Regarding short-term risk, BIMI is less volatile compared to MDVL. This indicates potentially lower risk in terms of short-term price fluctuations for BIMI.
BIMI vs LFLYW Comparison
BIMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIMI stands at 9423.00. In comparison, LFLYW has a market cap of 722681.00. Regarding current trading prices, BIMI is priced at $0.00, while LFLYW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIMI currently has a P/E ratio of N/A, whereas LFLYW's P/E ratio is -0.06. In terms of profitability, BIMI's ROE is -2.93%, compared to LFLYW's ROE of +0.34%. Regarding short-term risk, BIMI and LFLYW have similar daily volatility (0.00).
BIMI vs LFLY Comparison
BIMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIMI stands at 9423.00. In comparison, LFLY has a market cap of 620692.00. Regarding current trading prices, BIMI is priced at $0.00, while LFLY trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIMI currently has a P/E ratio of N/A, whereas LFLY's P/E ratio is -0.09. In terms of profitability, BIMI's ROE is -2.93%, compared to LFLY's ROE of +0.34%. Regarding short-term risk, BIMI is less volatile compared to LFLY. This indicates potentially lower risk in terms of short-term price fluctuations for BIMI.